Clinical trials
Active, not recruiting Digestive System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 5 |
| Vir Biotechnology, Inc. | 2 |
| Arizona State University | 1 |
| Boston Scientific Corporation | 1 |
| Claus Lindbjerg Andersen | 1 |
| Eli Lilly and Company | 1 |
| Gut-Brain-Axis Therapeutics Inc. | 1 |
| IDRX, Inc., a wholly owned subsidiary of GSK, LLC | 1 |
| Indiana University | 1 |
| Mirum Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Digestive System Diseases | 26 |
| Neoplasms | 6 |
| Digestive System Neoplasms | 5 |
| Colonic Diseases | 4 |
| Colonic Neoplasms | 4 |
| Colorectal Neoplasms | 4 |
| Gastrointestinal Diseases | 4 |
| Gastrointestinal Neoplasms | 4 |
| Intestinal Diseases | 4 |
| Liver Diseases | 4 |
Trials
Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.